ATGAM 50 mg/ml, concentrate for solution for infusion 5 ampoules of 5 ml
Active ingredients: IMMUNOGLOBULINE ÉQUINE ANTI-LYMPHOCYTE T HUMAIN
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only, hospital use
Concentrate for solution for infusion5 ampoules of 5 mlintraveineuse
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- ATGAM 50 mg/mL, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoules en verre de 5 mL
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 28 Feb 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
60589496CIP75508698CIP133400955086987Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IMMUNOGLOBULINE ÉQUINE ANTI-LYMPHOCYTE T HUMAINsolution | 50 mg · 1 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.